Kathmandu/UNI/XINHUA: Over two-thirds of Nepal's population has developed antibodies against COVID-19, as shown by a nationwide survey conducted by the Ministry of Health and Population (MoHP).
Barcelona: The levels of IgG antibodies against SARS-CoV-2 Spike protein remain stable, or even increase, seven months after infection, according to a follow-up study in a cohort of healthcare workers coordinated by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation, in collaboration with the Hospital Clinic of Barcelona.
Budapest: A Hungarian study has found China's Sinopharm vaccines failed to produce sufficient antibodies in a quarter of elderly people who were voluntarily tested in Budapest, media reports said.
Washington: A study conducted by the US' National Institute of Health has said India's COVAXIN, which was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, neutralises both Alpha and Delta variants of COVID-19.
New Delhi: A fifth serological survey conducted in New Delhi has found that more than 56 percent of residents in Delhi have been exposed to the coronavirus and they have developed antibodies for the infection, government revealed on Tuesday.
London: Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection against the new viral strain.
Jerusalem/Xinhua: Israeli researchers have been developing an antibody cocktail to treat and prevent COVID-19, Tel Aviv University (TAU) in central Israel said on Sunday.
Geneva/IBNS: Hours after the World Health Organization claimed that recovery from coronavirus might not shield a person from reinfection, the global health body has clarified that people who are infected with COVID-19 will develop an antibody response that will provide some level of protection.
London, Dec 12 (IBNS): A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.